BinitaShahAsharMD, MBA, FACS
General Surgery • Silver Spring, MDDirector, Office of Surgical and Infection Control Devices US FDA
Dr. Ashar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Hfz-410
Silver Spring, MD 20993Phone+1 301-796-6385
Education & Training
Cleveland Clinic FoundationResidency, Surgery, 1993 - 1998
Ohio State University College of MedicineClass of 1993
Certifications & Licensure
MD State Medical License 1998 - 2025
VA State Medical License 2013 - 2024- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Commentary on: US FDA Patient Decision Checklist for Breast Implants: Results of a Survey to Members of The Aesthetic Society, April 2022.Binita S Ashar
Aesthetic Surgery Journal. 2023-02-03 - 49 citationsBest Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.Elaine S. Jaffe, Binita S. Ashar, Mark W. Clemens, Andrew L. Feldman, Philippe Gaulard
Journal of Clinical Oncology. 2020-02-11 - Breast Implant-Associated Anaplastic Large Cell Lymphoma.Binita S. Ashar, Sung W. Yoon, Steven Nagel
American Family Physician. 2020-01-01
Press Mentions
FDA Orders New Restrictions, Stronger Warnings for Breast ImplantsOctober 28th, 2021- Health Highlights: April 1, 2021April 1st, 2021
- FDA Authorizes First Surgical Robot to Help with Transvaginal HysterectomiesMarch 1st, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
